West Pharmaceutical Services Finance Lease Liability Payments Due decreased by 11.9% to $5.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.2%, from $4.40M to $5.20M. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates higher debt-like obligations, potentially increasing financial risk.
This represents the total undiscounted future cash payments required under finance lease agreements. Unlike operating le...
Standard metric for companies with significant capital expenditure in leased equipment or facilities.
other_finance_lease_liability_payments_due| Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $3.60M | $3.40M | $4.40M | $5.40M | $5.90M | $5.20M |
| QoQ Change | — | -5.6% | +29.4% | +22.7% | +9.3% | -11.9% |
| YoY Change | — | — | — | +50.0% | +73.5% | +18.2% |